Optometrists in Orland Hills, IL Accepting Medicare
4 Optometrists found. Showing 1 - 4
 Trotta Eye Care Pc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 9245 159th St, Orland Hills, IL 60487 Phone: 630-740-1657 Fax: 708-349-4359 |
 Saja Hamayel, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 9265 159th St, Orland Hills, IL 60487 Phone: 708-349-4360 |
 Mr. Daniel John Trotta, OD Optometrist Medicare: Medicare Enrolled Practice Location: 9265 W 159th Street, Orland Hills, IL 60477 Phone: 708-349-4360 Fax: 708-349-4359 |
Dr. Henna Jawdi, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 9265 159th St, Orland Hills, IL 60487 Phone: 708-349-4360 |
News Archive
Study on placebo effect
A short time ago, Swedish scientists published a paper suggesting the existence of a genetic disposition to respond to placebo, thus giving rise to debate in the media about a possible "placebo gene." In the current issue of Deutsches Ärzteblatt International (Dtsch Arztebl Int 2009; 106[46]: 751-5), Matthias Breidert and Karl Hofbauer summarize the most recent data about placebos.
Cytheris initiates ORVACS Phase II clinical trial to study HIV infection
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced the initiation of Phase II clinical trial of the company's investigative immunomodulatory agent, CYT107 (rhIL-7), in combination with two potent antiretroviral drugs represented by the integrase inhibitor raltegravir (ISENTRESS- Merck & Co.) and the CCR5 inhibitor, maraviroc (SELZENTRY- ViiV Healthcare).
Individuals' views on health law form hopes, predictions about the Supreme Court's decision
New polls from the Kaiser Family Foundation and Bloomberg explore what the public expects of the high court's proceedings.
Jindal, campaigning for Romney, laments that health law will penalize 6 million people
The Louisiana governor denies ties between Romney's health law in Massachusetts and the national overhaul championed by President Barack Obama.
Vertex announces abstracts from hepatitis C program to be presented at The Liver Meeting
Vertex Pharmaceuticals Incorporated today announced that abstracts from its hepatitis C program, including two late-breaking posters from studies of INCIVEK (telaprevir) tablets and VX-222, were accepted for presentation at The Liver Meeting, the 62nd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) in San Francisco, November 4-8, 2011.
› Verified 9 days ago
Physical Therapists
Optometrists
Chiropractors
Audiologists
Speech-Language Pathologists
Podiatrists
Occupational Therapists